Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, March 2, 2017
[ Thu, Mar 02nd 2017
] - WOPRAI
[ Thu, Mar 02nd 2017
] - WOPRAI
[ Thu, Mar 02nd 2017
] - WOPRAI
[ Thu, Mar 02nd 2017
] - WOPRAI
[ Thu, Mar 02nd 2017
] - WOPRAI
[ Thu, Mar 02nd 2017
] - WOPRAI
[ Thu, Mar 02nd 2017
] - WOPRAI
[ Thu, Mar 02nd 2017
] - WOPRAI
[ Thu, Mar 02nd 2017
] - WOPRAI
[ Thu, Mar 02nd 2017
] - WOPRAI
[ Thu, Mar 02nd 2017
] - WOPRAI
[ Thu, Mar 02nd 2017
] - WOPRAI
[ Thu, Mar 02nd 2017
] - WOPRAI
[ Thu, Mar 02nd 2017
] - WOPRAI
[ Thu, Mar 02nd 2017
] - WOPRAI
[ Thu, Mar 02nd 2017
] - WOPRAI
[ Thu, Mar 02nd 2017
] - WOPRAI
[ Thu, Mar 02nd 2017
] - WOPRAI
[ Thu, Mar 02nd 2017
] - WOPRAI
[ Thu, Mar 02nd 2017
] - WOPRAI
[ Thu, Mar 02nd 2017
] - WOPRAI
[ Thu, Mar 02nd 2017
] - WOPRAI
[ Thu, Mar 02nd 2017
] - WOPRAI
[ Thu, Mar 02nd 2017
] - WOPRAI
[ Thu, Mar 02nd 2017
] - WOPRAI
Christopher Marai Initiated (SRPT) at Strong Buy on, Mar 2nd, 2017
Christopher Marai of Nomura, Initiated "Sarepta Therapeutics, Inc." (SRPT) at Strong Buy on, Mar 2nd, 2017.
Christopher has made no other calls on SRPT in the last 4 months.
There is 1 other peer that has a rating on SRPT. Out of the 1 peers that are also analyzing SRPT, 0 agree with Christopher's Rating of Hold.
This is the rating of the analyst that currently disagrees with Christopher
- Anupam Rama of "JP Morgan" Initiated at Buy and Held Target at $40 on, Thursday, December 22nd, 2016
Similar Stocks and Investing Articles
[ Fri, Feb 17th 2017
] - WOPRAI
[ Mon, Jan 09th 2017
] - WOPRAI
[ Thu, Dec 22nd 2016
] - WOPRAI
[ Mon, Jul 11th 2016
] - WOPRAI
[ Tue, Dec 22nd 2015
] - WOPRAI
[ Wed, Apr 22nd 2015
] - WOPRAI
[ Fri, Feb 27th 2015
] - WOPRAI
[ Tue, Dec 02nd 2014
] - WOPRAI
[ Tue, Feb 11th 2014
] - WOPRAI
[ Tue, Mar 06th 2012
] - WOPRAI